Public-Private Mix (PPM) for TB prevention and care
Engaging all relevant health care providers in TB care and control through public-private mix approaches is an essential component of WHO's End TB Strategy. Public-Private Mix (PPM) for TB Care and Control represents a comprehensive approach for systematic involvement of all relevant health care providers in TB control to promote the use of International Standards for TB Care and achieve national and global TB control targets. PPM encompasses diverse collaborative strategies such as public-private (between NTP and the private sector), public-public (between NTP and other public sector care providers such as general hospitals, prison or military health services and social security organizations), and private-private (between an NGO or a private hospital and the neighborhood private providers) collaboration.
News and events
14 February - 16 February 2017
The 12th Global Meeting on Public-Private Mix (PPM) for TB Care and Prevention was held in Dar es Salaam, Tanzania from 14-16 February 2017. The meeting discussed global progress and challenges to expanding PPM with a view to address the persistent global problem of missed TB cases. Strategies to bring about behaviour change among private providers and those for better governance and sustainable financing of PPM interventions were also deliberated upon.
29 February - 2 March 2016
Working with frontline private providers: innovations in scaling up collaboration and regulation The meeting of the full PPM working group was organized in Mumbai on 29 February to 2 March 2016 with the theme “Working with frontline private providers: innovations in scaling up collaboration and regulation”. Over 140 representatives from 15 countries, partners, civil society and other agencies participated in the meeting. Field visits were organized to PATH PPIA model sites in Mumbai. The meeting reviewed global progress on and challenges to PPM expansion as well as innovations in scaling up collaboration with and regulation of private providers including laboratories and pharmacies. An overview was presented and discussed on approaches to costing and sustainable financing to scale up PPM innovations in the context of the new End TB Strategy. Participants also had a first-hand experience of the various components of the model and operations at the field level.